Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Study - OPTIMAL - Arm F-A, R-CHOP 14 - Rituximab 375 / Cyclophosphamide 750 / Doxorubicin 50 / Vincristine 2 / Prednisolone 100, diffuse large B-non-Hodgkin Lymphoma

Protocol-ID: 1124 V1.0 (Mini), STUDY-OPTIMAL - ARM F-A, R-CHOP 14, DLBCL
Study protocol, available to authorized participants only.

Indication(s)

  • NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
  • NHL, B-Cell Type, Follicular grade IIIb; ICD-10 C82.-, C82.7, C82.9
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 14.06.2018